Articles By Topic:


Optimizing Approaches to Treating Medullary Thyroid Cancer

Total thyroidectomy with central lymph node dissection is recommended in patients with medullary thyroid cancer. New research suggests that the number of lymph node metastases should be incorporated into staging of the disease and that surgery should be tailored to tumor.

Relieving Pain in Colorectal Surgery

Researchers have developed enhanced recovery pathways (ERP) to improve outcomes and reduce readmissions in colorectal surgery patients. “ERP protocols use a set of standardized pre- and postoperative orders,” explains Conor P. Delaney, MD, PhD, FACS, FASCRS. “Research clearly shows that these protocols can help speed recovery and improve outcomes.” ERP protocols emphasize early mobilization after surgery, optimal analgesia, and control of intravenous fluid volumes.…

Proton Therapy for Prostate Cancer: Assessing Long-Term Results

Proton therapy appears to be highly effective for low-,intermediate-, and high-risk prostate cancer patients and offers the added benefits of being minimally toxic. The procedure appears to have excellent patient-reported outcomes among men with the disease.


Diagnosing & Staging Esophageal Cancer

The overall 5-year survival rates for esophageal cancer are less than 15%. Although esophagectomy has been the traditional gold standard for early stage disease, optimal treatment for localized disease has generated debate in light of the overall poor survival rate. In 2013, the Society of Thoracic Surgeons (STS) published a set of clinical practice guidelines for the diagnosis and treatment of localized esophageal cancer in Annals of Thoracic Surgery.…

Palliative Care for Metastatic Cancer

Nearly half of all patients with metastatic cancer have incurable disease, but these individuals can live for years after their initial diagnosis. This is a period in which palliative care can be used to improve quality of life (QOL) for patients and caregivers.…

Breast-Conserving Surgery for Invasive Breast Cancer

Despite recent improvements in imaging technology, pathology assessments, and the use of systemic therapy, there is still controversy regarding the optimal margin width in breast-conserving surgery. About 25% of patients with invasive breast cancer return to the operating room after undergoing lumpectomy to obtain more widely clear margins.…


Medicine 2064

Medicine 2064 With Dr. Daniel Kraft

Curing half of the world’s known cancers, granting movement to the paralyzed, preventing Alzheimer’s. Visionary medical expert Dr. Daniel Kraft believes all of this and more can happen by 2064. In this first film in our “Conversations with Tomorrow” series, take a glimpse at the future of medicine and its impact on our lives.…

The Immune System Explained: A Patient Education Video

For Healthcare Providers:
The immune systems is an exceptionally complex system that is hard to grasp for most patients, and even many of your colleagues. Share this video with your patients to provide them with a simplified, yet quite informative, explanation of how the system works.…

Media Flub: Squeezing Breasts Prevents Cancer?

Breast cancer is not funny. The media squeezing sensationalism out of research is misleading and trivializes a serious problem.


Smart Knife Detects Cancer Cells During Tumor Surgery

An “intelligent knife” that can immediately determine whether tissue is healthy or cancerous was 100% accurate in the first study to test the device in the operating room.

Known as the iKnife, the innovative tool combines electrosurgery with rapid evaporative ionization mass spectrometry.…

PSA Screening: More Harm Than Good

A new analysis presented at the European Cancer Conference 2013 adds fuel to the ongoing debate over whether routine prostate cancer screening reduces prostate cancer mortality. Overall, lead author Mathieu Boniol, MD, and colleagues found that the harms outweigh the benefits on a population level—which should further discourage the use of routine PSA testing for prostate cancer in the general population.…

Updated Breast Cancer Guidelines for HER2 Testing

A new update to clinical practice guidelines for HER2 testing in breast cancer was published online last week by the American Society of Clinical Oncology and the College of American Pathologists in the Journal of Clinical Oncology.

The guidelines recommend that all women with invasive breast cancer (primary or recurrence) are tested for HER2 status—a practice already being implemented across the United States.…

eMedia - Oncology




Physician's Weekly for Current Medical News, Events & Issues